 Connection
Daniel Ambruso to Granulomatous Disease, Chronic
This is a "connection" page, showing publications Daniel Ambruso has written about Granulomatous Disease, Chronic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.865 |
|
|
|
-
Ambruso DR, Briones NJ, Tran AD, Sanford B, Childs C, Katz BZ, Ellison M, Johnston RB, Jones KL. Interferon-gamma 1b-induced gene expression alters neutrophil function in patients with chronic granulomatous disease. PLoS One. 2025; 20(9):e0331657.
Score: 0.907
-
McKinney C, Ambruso D. Non-Infectious Complications of Chronic Granulomatous Disease: Knowledge Gaps & Novel Treatment Considerations. Immunol Allergy Clin North Am. 2025 05; 45(2):287-298.
Score: 0.876
-
Ambruso DR, Briones NJ, Baroffio AF, Murphy JR, Tran AD, Gowan K, Sanford B, Ellison M, Jones KL. In vivo interferon-gamma induced changes in gene expression dramatically alter neutrophil phenotype. PLoS One. 2022; 17(2):e0263370.
Score: 0.707
-
Knipstein JA, Ambruso DR. Sweet syndrome in an infant with chronic granulomatous disease. J Pediatr Hematol Oncol. 2012 Jul; 34(5):372-4.
Score: 0.364
-
Gardai S, Whitlock BB, Helgason C, Ambruso D, Fadok V, Bratton D, Henson PM. Activation of SHIP by NADPH oxidase-stimulated Lyn leads to enhanced apoptosis in neutrophils. J Biol Chem. 2002 Feb 15; 277(7):5236-46.
Score: 0.011
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|